{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T19:06:37Z","timestamp":1781723197496,"version":"3.54.5"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T00:00:00Z","timestamp":1726876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007786","name":"National Center for Child Health and Development","doi-asserted-by":"publisher","award":["2024C-25"],"award-info":[{"award-number":["2024C-25"]}],"id":[{"id":"10.13039\/100007786","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007786","name":"National Center for Child Health and Development","doi-asserted-by":"publisher","award":["2023C-27"],"award-info":[{"award-number":["2023C-27"]}],"id":[{"id":"10.13039\/100007786","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007786","name":"National Center for Child Health and Development","doi-asserted-by":"publisher","award":["2021B-18"],"award-info":[{"award-number":["2021B-18"]}],"id":[{"id":"10.13039\/100007786","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007786","name":"National Center for Child Health and Development","doi-asserted-by":"publisher","award":["2020B-18"],"award-info":[{"award-number":["2020B-18"]}],"id":[{"id":"10.13039\/100007786","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Government of Japan Ministry of Education Culture Sports Science and Technology","doi-asserted-by":"publisher","award":["23K07949"],"award-info":[{"award-number":["23K07949"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Government of Japan Ministry of Education Culture Sports Science and Technology","doi-asserted-by":"publisher","award":["21K08634"],"award-info":[{"award-number":["21K08634"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Government of Japan Ministry of Education Culture Sports Science and Technology","doi-asserted-by":"publisher","award":["23K08062"],"award-info":[{"award-number":["23K08062"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Government of Japan Ministry of Education Culture Sports Science and Technology","doi-asserted-by":"publisher","award":["23K14668"],"award-info":[{"award-number":["23K14668"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.neo.2024.101061","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T15:50:59Z","timestamp":1727797859000},"page":"101061","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Targeted immune cell therapy for hepatocellular carcinoma using expanded liver mononuclear cell-derived natural killer cells"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3919-870X","authenticated-orcid":false,"given":"Xin","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifang","family":"Shui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seisuke","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mureo","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Zhi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0897-2141","authenticated-orcid":false,"given":"Xiao-Kang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2024.101061_bib0001","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00262-016-1792-y","article-title":"Selection and expansion of natural killer cells for NK cell-based immunotherapy","volume":"65","author":"Becker","year":"2016","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.neo.2024.101061_bib0002","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41423-021-00808-3","article-title":"Advances in NK cell production","volume":"19","author":"Fang","year":"2022","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.neo.2024.101061_bib0003","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s12185-018-2407-5","article-title":"NK cell therapy for hematologic malignancies","volume":"107","author":"Mehta","year":"2018","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.neo.2024.101061_bib0004","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/hep.21035","article-title":"Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans","volume":"43","author":"Ishiyama","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.neo.2024.101061_bib0005","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1016\/j.cell.2023.07.034","article-title":"A pan-cancer single-cell panorama of human natural killer cells","volume":"186","author":"Tang","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.neo.2024.101061_bib0006","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00281-021-00877-6","article-title":"The role of natural killer cells in liver inflammation","volume":"43","author":"Highton","year":"2021","journal-title":"Semin Immunopathol."},{"key":"10.1016\/j.neo.2024.101061_bib0007","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.immuni.2018.12.024","article-title":"Liver-resident NK cells control antiviral activity of hepatic T cells via the PD-1-PD-L1 axis","volume":"50","author":"Zhou","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.neo.2024.101061_bib0008","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3389\/fimmu.2019.00946","article-title":"Hepatic natural killer cells: organ-specific sentinels of liver immune homeostasis and physiopathology","volume":"10","author":"Mikulak","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neo.2024.101061_bib0009","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/s41467-023-37181-w","article-title":"Control of human cytomegalovirus replication by liver resident natural killer cells","volume":"14","author":"Forrest","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2024.101061_bib0010","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1097\/01.tp.0000250935.41034.2d","article-title":"Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy","volume":"82","author":"Ohira","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.neo.2024.101061_bib0011","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/lt.22080","article-title":"Liver grafts contain a unique subset of natural killer cells that are transferred into the recipient after liver transplantation","volume":"16","author":"Moroso","year":"2010","journal-title":"Liver Transp."},{"key":"10.1016\/j.neo.2024.101061_bib0012","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cell.2017.09.052","article-title":"ILC1 confer early host protection at initial sites of viral infection","volume":"171","author":"Weizman","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.neo.2024.101061_bib0013","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/hep.1840050321","article-title":"Immunologic analysis of mononuclear cells in liver tissues and blood of patients with primary sclerosing cholangitis","volume":"5","author":"Whiteside","year":"1985","journal-title":"Hepatology"},{"key":"10.1016\/j.neo.2024.101061_bib0014","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/imm.12120","article-title":"Natural killer cell-mediated contact sensitivity develops rapidly and depends on interferon-alpha, interferon-gamma and interleukin-12","volume":"140","author":"Majewska-Szczepanik","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.neo.2024.101061_bib0015","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00262-022-03276-4","article-title":"PD-L1 antibody enhanced \u03b2-glucan antitumor effects via blockade of the immune checkpoints in a melanoma model","volume":"72","author":"Hu","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.neo.2024.101061_bib0016","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3727\/096368911X627589","article-title":"Clinical-scale isolation of interleukin-2-stimulated liver natural killer cells for treatment of liver transplantation with hepatocellular carcinoma","volume":"21","author":"Ohira","year":"2012","journal-title":"Cell Transplant"},{"key":"10.1016\/j.neo.2024.101061_bib0017","first-page":"88","article-title":"Activation of natural killer cells during microbial infections","volume":"2","author":"Horowitz","year":"2011","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neo.2024.101061_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113285","article-title":"The Immune Checkpoint PD-1 in Natural Killer Cells: Expression, Function and Targeting in Tumour Immunotherapy","volume":"12","author":"Quatrini","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.neo.2024.101061_bib0019","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jim.2004.08.008","article-title":"CD107a as a functional marker for the identification of natural killer cell activity","volume":"294","author":"Alter","year":"2004","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.neo.2024.101061_bib0020","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1182\/blood-2012-07-441832","article-title":"Surface CD107a\/LAMP-1 protects natural killer cells from degranulation-associated damage","volume":"122","author":"Cohnen","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.neo.2024.101061_bib0021","doi-asserted-by":"crossref","DOI":"10.3791\/54615-v","article-title":"Flow cytometry-based assay for the monitoring of NK cell functions","author":"Tognarelli","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.neo.2024.101061_bib0022","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1158\/1078-0432.CCR-21-0851","article-title":"Memory-like differentiation enhances NK cell responses to melanoma","volume":"27","author":"Marin","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2024.101061_bib0023","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.4049\/jimmunol.179.6.3812","article-title":"Granzyme B activity in target cells detects attack by cytotoxic lymphocytes","volume":"179","author":"Packard","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.neo.2024.101061_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1087155","article-title":"NK cell education: physiological and pathological influences","volume":"14","author":"Rascle","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neo.2024.101061_bib0025","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.3389\/fimmu.2019.02354","article-title":"The rise of NK cell checkpoints as promising therapeutic targets in cancer immunotherapy","volume":"10","author":"Sun","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neo.2024.101061_bib0026","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41590-018-0132-0","article-title":"Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity","volume":"19","author":"Zhang","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.neo.2024.101061_bib0027","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1093\/brain\/awl205","article-title":"TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells","volume":"129","author":"Eisele","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neo.2024.101061_bib0028","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-6890-12-7","article-title":"Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas","volume":"12","author":"Sorbye","year":"2012","journal-title":"BMC Clin. Pathol."},{"key":"10.1016\/j.neo.2024.101061_bib0029","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1073\/pnas.092141999","article-title":"MIP-1alpha, MIP-1beta, RANTES, and ATAC\/lymphotactin function together with IFN-gamma as type 1 cytokines","volume":"99","author":"Dorner","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neo.2024.101061_bib0030","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.31557\/APJCP.2021.22.4.1069","article-title":"Establishment of nude mice lacking NK cells and their application for human tumor xenografts","volume":"22","author":"Panaampon","year":"2021","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.neo.2024.101061_bib0031","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22169044","article-title":"Natural killer cells and type 1 innate lymphoid cells in hepatocellular carcinoma: current knowledge and future perspectives","volume":"22","author":"Jacquelot","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neo.2024.101061_bib0032","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.7314\/APJCP.2012.13.11.5909","article-title":"Associations between infiltrating lymphocyte subsets and hepatocellular carcinoma","volume":"13","author":"Guo","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.neo.2024.101061_bib0033","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/hep.26192","article-title":"Monocyte\/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48\/2B4 interactions","volume":"57","author":"Wu","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.neo.2024.101061_bib0034","doi-asserted-by":"crossref","DOI":"10.3390\/cells10030614","article-title":"Intratumor regulatory noncytotoxic NK cells in patients with hepatocellular carcinoma","volume":"10","author":"Zecca","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.neo.2024.101061_bib0035","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13327","article-title":"Deciphering the tumour immune microenvironment of hepatocellular carcinoma","volume":"98","author":"Liu","year":"2023","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.neo.2024.101061_bib0036","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13058-017-0867-9","article-title":"Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours","volume":"19","author":"Shenouda","year":"2017","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.neo.2024.101061_bib0037","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12943-020-01238-x","article-title":"Natural killer cells in cancer biology and therapy","volume":"19","author":"Wu","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.neo.2024.101061_bib0038","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.it.2017.02.008","article-title":"Liver-resident NK cells: the human factor","volume":"38","author":"Male","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.neo.2024.101061_bib0039","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1007\/s11427-016-0334-2","article-title":"Tissue-resident natural killer cells in the livers","volume":"59","author":"Peng","year":"2016","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.neo.2024.101061_bib0040","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.4049\/jimmunol.1001637","article-title":"Immature NK cells, capable of producing IL-22, are present in human uterine mucosa","volume":"185","author":"Male","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.neo.2024.101061_bib0041","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1002\/eji.201141760","article-title":"NK cells can generate from precursors in the adult human liver","volume":"41","author":"Moroso","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.neo.2024.101061_bib0042","unstructured":"(!!! INVALID CITATION !!! 43)."},{"key":"10.1016\/j.neo.2024.101061_bib0043","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.4049\/jimmunol.162.4.1988","article-title":"Fas ligand induction in human NK cells is regulated by redox through a calcineurin-nuclear factors of activated T cell-dependent pathway","volume":"162","author":"Furuke","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.neo.2024.101061_bib0044","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10120-012-0210-1","article-title":"Increased apoptosis and elevated Fas expression in circulating natural killer cells in gastric cancer patients","volume":"16","author":"Saito","year":"2013","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.neo.2024.101061_bib0045","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3390\/s90100386","article-title":"Human NK cell up-regulation of CD69, HLA-DR, interferon gamma secretion and cytotoxic activity by plasmacytoid dendritic cells is regulated through overlapping but different pathways","volume":"9","author":"Benlahrech","year":"2009","journal-title":"Sensors"},{"key":"10.1016\/j.neo.2024.101061_bib0046","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1002\/1521-4141(200010)30:10<2791::AID-IMMU2791>3.0.CO;2-D","article-title":"Regulation of p38 mitogen-activated protein kinase during NK cell activation","volume":"30","author":"Chini","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.neo.2024.101061_bib0047","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.2147\/COPD.S103758","article-title":"Interleukin-16-producing NK cells and T-cells in the blood of tobacco smokers with and without COPD","volume":"11","author":"Andersson","year":"2016","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.neo.2024.101061_bib0048","doi-asserted-by":"crossref","first-page":"10139","DOI":"10.1073\/pnas.1600112113","article-title":"NK cells activated by Interleukin-4 in cooperation with Interleukin-15 exhibit distinctive characteristics","volume":"113","author":"Kiniwa","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neo.2024.101061_bib0049","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41591-018-0085-8","article-title":"A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments","volume":"24","author":"Barry","year":"2018","journal-title":"Nat. Med."}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558624001027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558624001027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T20:48:35Z","timestamp":1731012515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558624001027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":49,"alternative-id":["S1476558624001027"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2024.101061","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted immune cell therapy for hepatocellular carcinoma using expanded liver mononuclear cell-derived natural killer cells","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2024.101061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101061"}}